MedPath

BIO-TADALAFIL

BIO-TADALAFIL

Approved
DIN Number

02508702

Drug Class

Human

Market Date

N/A

Company
HC

biomed pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02508702
AIG Number0149485004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BE08 TADALAFIL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:12.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

TADALAFILActive
Strength: 5 MG
Monograph: TADALAFIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.